Lawmakers ask FDA for timeline on reclassifying hydrocodone

02/17/2013 | Hill, The · Pharmalot.com

Seven U.S. lawmakers asked the FDA to create a time frame for reclassifying hydrocodone drugs from Schedule III to Schedule II. The change would mean patients would need a physician's written prescription to be able to purchase the medications.

View Full Article in:

Hill, The · Pharmalot.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT